Cargando…
Biosimilars in dermatology
Over the last decade the availability of biological drugs for the treatment of psoriasis vulgaris, psoriatic arthritis and many other inflammatory diseases has revolutionized the treatment of these diseases around the world. Due to the high cost of therapy, the search has started for biosimilars. In...
Autores principales: | Mazur, Małgorzata, Olek-Hrab, Karolina, Karczewski, Jacek, Teresiak-Mikołajczak, Ewa, Adamski, Zygmunt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692813/ https://www.ncbi.nlm.nih.gov/pubmed/26759547 http://dx.doi.org/10.5114/pdia.2014.44026 |
Ejemplares similares
-
Mycosis fungoides: therapeutic difficulties
por: Adamska, Kinga, et al.
Publicado: (2015) -
Genetic polymorphism in psoriasis and its meaning for the treatment efficacy in the future
por: Osmola-Mańkowska, Agnieszka, et al.
Publicado: (2018) -
Primary cutaneous lymphomas: diagnosis and treatment
por: Sokołowska-Wojdyło, Małgorzata, et al.
Publicado: (2015) -
The role of dendritic cells and regulatory T cells in the pathogenesis of morphea
por: Osmola-Mańkowska, Agnieszka, et al.
Publicado: (2015) -
Effects of UVA1 Phototherapy on Expression of Human Endogenous Retroviral Sequence (HERV)-K10 gag in Morphea: A Preliminary Study
por: Kowalczyk, Michał Jacek, et al.
Publicado: (2017)